Alterations in platelet activity and endothelial glycocalyx biomarkers by treatment with an angiotensin converting enzyme inhibitor or an alpha-1 adrenoceptor antagonist in patients with hypertension: results from the DoRa study
Drugs blocking the renin–angiotensin–aldosterone system may offer benefit on endothelial function, inflammation, and hemostasis in addition to the effects of reducing blood pressure. We have shown antithrombin effects by treatment with the angiotensin converting enzyme (ACE) inhibitor ramipril. As t...
Guardado en:
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Taylor & Francis Group
2024-12-01
|
| Colección: | Platelets |
| Materias: | |
| Acceso en línea: | https://www.tandfonline.com/doi/10.1080/09537104.2024.2437768 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|